Laurus Labs Unternehmensprofil

LAURUSLABS · NSE · INR

1.971,40 ₹Veränderung zum vorherigen Schlusskurs: −0,64 %Absolute Veränderung: −12,60 ₹

Schlusskurs · 5. Oktober 2026

Unternehmensprofil

Laurus Labs hat 7.059 Mitarbeiter und den Hauptsitz in Hyderabad, Indien.

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Beschreibung auf Englisch verfügbar.

Unternehmensdaten

Branche
Gesundheit
Industrie
Drug Manufacturers - Specialty & Generic
Land
Indien
Hauptsitz
Jubilee Hills, 500033, Hyderabad
Mitarbeitende
7.059
Notierung
LAURUSLABS · NSE
Währung
INR